By Abigail Summerville
(Reuters) – Physician’s Choice, a U.S. maker of supplements and probiotics, is exploring a sale that could value the company at over $500 million, according to sources familiar with the matter.
The founder-owned company, which says that it is the best- selling probiotic on Amazon.com, is working with investment bank CG Sawaya Partners on the sale process, the sources said. Physician’s Choice generates around $200 million of revenue annually, they said.
The sources said no deal was guaranteed and spoke on condition of anonymity to discuss private information.
Physician’s Choice and CG Sawaya did not respond to requests for comment.
Logan Chierotti launched the company in 2017 to make health supplements more accessible. According to the company’s website, Chierotti was inspired by a childhood head injury which left him deaf in one ear, and the role he credits supplements as having in restoring his hearing.
The Colorado-based company has a “Scientific Advisory Board” made up of doctors, scientists, and researchers who approve supplement formulas to address gut health and general wellness.
Besides Amazon.com, Physician’s Choice is available at retailers including Target and Walmart.
Consumer health companies and private equity firms have acquired vitamins and supplements brands in recent years. Two weeks ago, private equity-owned Wellful announced an agreement to acquire vitamins maker Ancient Nutrition.
In 2023, Sanofi bought vitamins company Qunol. And in June, Reuters reported that probiotics maker Seed Health was exploring a sale.
(Reporting by Abigail Summerville in New York; Editing by Muralikumar Anantharaman)
